EGFR inhibitors
The application provides a compound having the general formula (I) or a pharmaceutically acceptable salt thereof, compositions including the compound and methods of using the compound. The compound of formula (I) can be used as a medicament.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
12.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The application provides a compound having the general formula (I) or a pharmaceutically acceptable salt thereof, compositions including the compound and methods of using the compound. The compound of formula (I) can be used as a medicament. |
---|---|
Bibliography: | Application Number: AU20200405326 |